These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30761083)

  • 1. History of the Obesogen Field: Looking Back to Look Forward.
    Heindel JJ
    Front Endocrinol (Lausanne); 2019; 10():14. PubMed ID: 30761083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesogens: an emerging threat to public health.
    Janesick AS; Blumberg B
    Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine disruptors and obesity.
    Heindel JJ; Newbold R; Schug TT
    Nat Rev Endocrinol; 2015 Nov; 11(11):653-61. PubMed ID: 26391979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity II: Establishing causal links between chemical exposures and obesity.
    Heindel JJ; Howard S; Agay-Shay K; Arrebola JP; Audouze K; Babin PJ; Barouki R; Bansal A; Blanc E; Cave MC; Chatterjee S; Chevalier N; Choudhury M; Collier D; Connolly L; Coumoul X; Garruti G; Gilbertson M; Hoepner LA; Holloway AC; Howell G; Kassotis CD; Kay MK; Kim MJ; Lagadic-Gossmann D; Langouet S; Legrand A; Li Z; Le Mentec H; Lind L; Monica Lind P; Lustig RH; Martin-Chouly C; Munic Kos V; Podechard N; Roepke TA; Sargis RM; Starling A; Tomlinson CR; Touma C; Vondracek J; Vom Saal F; Blumberg B
    Biochem Pharmacol; 2022 May; 199():115015. PubMed ID: 35395240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence.
    Kurşunoğlu NE; Sarer Yurekli BP
    World J Clin Cases; 2022 Nov; 10(31):11226-11239. PubMed ID: 36387809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and endocrine-disrupting chemicals.
    Amato AA; Wheeler HB; Blumberg B
    Endocr Connect; 2021 Feb; 10(2):R87-R105. PubMed ID: 33449914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental Obesogens: Mechanisms and Controversies.
    Heindel JJ; Blumberg B
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():89-106. PubMed ID: 30044726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.
    Chen JQ; Brown TR; Russo J
    Biochim Biophys Acta; 2009 Jul; 1793(7):1128-43. PubMed ID: 19348861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ENDOCRINE DISRUPTING CHEMICALS AND OBESITY: THE EVOLVING STORY OF OBESOGENS.
    Micić D; Polovina S; Micić D; Macut D
    Acta Endocrinol (Buchar); 2021; 17(4):503-508. PubMed ID: 35747866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Research Approaches and Challenges in the Obesogen Field.
    Chamorro-Garcia R; Blumberg B
    Front Endocrinol (Lausanne); 2019; 10():167. PubMed ID: 30967838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine disrupting chemicals and growth of children.
    Botton J; Kadawathagedara M; de Lauzon-Guillain B
    Ann Endocrinol (Paris); 2017 Jun; 78(2):108-111. PubMed ID: 28483365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine Disrupting Chemicals, Transgenerational Epigenetics and Metabolic Diseases.
    Feroe A; Broene R; Albuquerque D; Ruiz P
    EC Endocrinol Metab Res; 2017 Nov; 21():31-51. PubMed ID: 34734213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine Disruptors and Obesity.
    Darbre PD
    Curr Obes Rep; 2017 Mar; 6(1):18-27. PubMed ID: 28205155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals.
    Stel J; Legler J
    Endocrinology; 2015 Oct; 156(10):3466-72. PubMed ID: 26241072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental Obesogens and Their Impact on Susceptibility to Obesity: New Mechanisms and Chemicals.
    Egusquiza RJ; Blumberg B
    Endocrinology; 2020 Mar; 161(3):. PubMed ID: 32067051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine Aspects of Environmental "Obesogen" Pollutants.
    Nappi F; Barrea L; Di Somma C; Savanelli MC; Muscogiuri G; Orio F; Savastano S
    Int J Environ Res Public Health; 2016 Jul; 13(8):. PubMed ID: 27483295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesogenic Endocrine Disrupting Chemicals: Identifying Knowledge Gaps.
    Veiga-Lopez A; Pu Y; Gingrich J; Padmanabhan V
    Trends Endocrinol Metab; 2018 Sep; 29(9):607-625. PubMed ID: 30017741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new kids on the block: Emerging obesogens.
    Chamorro-Garcia R; Veiga-Lopez A
    Adv Pharmacol; 2021; 92():457-484. PubMed ID: 34452694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenerational inheritance of prenatal obesogen exposure.
    Janesick AS; Shioda T; Blumberg B
    Mol Cell Endocrinol; 2014 Dec; 398(1-2):31-5. PubMed ID: 25218215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental Exposure to Endocrine Disrupting Chemicals and Type 1 Diabetes Mellitus.
    Howard SG
    Front Endocrinol (Lausanne); 2018; 9():513. PubMed ID: 30233498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.